UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:October 28,
RespireRx Pharmaceuticals (CE) (USOTC:RSPI)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more RespireRx Pharmaceuticals (CE) Charts.
RespireRx Pharmaceuticals (CE) (USOTC:RSPI)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more RespireRx Pharmaceuticals (CE) Charts.

Respirerx Pharmaceuticals Inc. News

Form 8-K - Current report
Tuesday 9 July 2024 (3 weeks ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 29 May 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Saturday 3 February 2024 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 23 January 2024 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 12 December 2023 (7 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 18 November 2023 (8 months ago) • Edgar (US Regulatory)
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Wednesday 15 November 2023 (8 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 13 October 2023 (9 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 2 October 2023 (10 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 22 August 2023 (11 months ago) • Edgar (US Regulatory)
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Tuesday 15 August 2023 (11 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 9 August 2023 (12 months ago) • Edgar (US Regulatory)

More Respirerx Pharmaceuticals Inc. News Articles